Are you Suffering from Permanent Hair loss as a Result of using Taxotere?
Did you know that a recent investigation into Sanofi Aventis revealed that the company knew their drug Taxotere® could cause permanent hair loss also known as Alopecia?
A recent lawsuit states that Sanofi Aventis failed to properly warn patients that alopecia was a potential side effect. Because they were not properly warned, patients were not aware that they could switch to another drug with no risk of Alopecia.
What is Taxotere?
Taxotere is a drug that is mainly used to treat breast cancer patients. However, it can also be used for non-small cell lung cancer, stomach (gastric) cancer, prostate cancer or head and neck cancer. Taxotere is used during chemotherapy to stop the growth and spread of cancer cells. It is mainly used in patients where cancer has spread or their bodies have not responded to doxorubicin.
The Manufacturers of Taxotere Failed to Properly Warn Patients about Possible Permanent Hair Loss
Its is no secret that chemotherapy may cause hair loss. However, the manufacturers of Taxotere failed to properly warn patients that hair loss associated with their drug is often permanent. Evidence shows Taxotere provided misleading information, stating that hair would grow back after using the drug.
Taxotere is FDA approved, However, since evidence of alopecia has been reported the FDA has updated the label on Taxotere to state the following:
"Cases of permanent alopecia have been reported."
What are other Side Effects Associated with Taxotere?
Has Taxotere been Recalled?
At this time Taxotere has not been recalled. Attorneys are working hard to make sure all those affected by Taxotere are taken care of. Always talk to your doctor about the use of Taxotere and what chemotherapy drug is best for you.
We are here to help Taxotere victims. Financial compensation may be available due to the irresponsibility of Taxotere manufacturers.